|
1
|
Ferlay J, Steliarova-Foucher E, Lortet
Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and Bray F:
Cancer incidence and mortality patterns in Europe: Estimates for 40
countries in 2012. Eur J Cancer. 49:1374–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Naishadham D and Jemal A:
Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sinclair P, Singh A, Riaz AA and Amin A:
An unsolved conundrum: The ideal follow up strategy after curative
surgery for colorectal cancer. Gastrointest Endosc. 75:1072–1079.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogelstein B, Fearon ER, Hamilton SR, Kern
SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos
JL: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan N, Kang R, Ge X, Li M, Liu Y, Chen HM
and Gao CF: Identification of alpha-2-HS-glycoprotein precursor and
tubulin beta chain as serology diagnosis biomarker of colorectal
cancer. Diagn Pathol. 12:532014. View Article : Google Scholar
|
|
6
|
Thomson DM, Krupey J, Freedman SO and Gold
P: The radioimmunoassay of circulating carcinoma bryonic antigen of
the human digestive system. Proc Natl Acad USA. 64:161–167. 1969.
View Article : Google Scholar
|
|
7
|
Duffy MJ: Role of tumor markers in
patients with solid cancers: A critical review. Eur J Intern Med.
18:175–184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hartwig JH and Stossel TP: Isolation and
properties of actin, myosin and a new actin-binding protein in
rabbit alveolar macrophages. J Biol Chem. 250:5696–5705.
1975.PubMed/NCBI
|
|
10
|
Stossel TP, Condeelis J, Cooley L, Hartwig
JH, Noegel A, Schleicher M and Shapiro SS: Filamins as integrators
of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2:138–145.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gomer RH and Lazarides E: Switching of
filamin polypeptides during myogenesis in vitro. J Cell Biol.
96:321–329. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Savoy RM and Ghosh PM: The dual role of
filamin a in cancer: Can't live with (too much of) it, can't live
without it. Endocr Relat Cancer. 20:R341–R356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Djinovic-Carugo K and Carugo O: Structural
portrait of filamin interaction mechanisms. Cur Protein Pept Sci.
11:639–650. 2010. View Article : Google Scholar
|
|
14
|
Xu YJ, Bismar TA, Su J, Xu B, Kristiansen
G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R and Alaoui-Jamali
MA: Filamin a regulates focal adhesion disassembly and suppresses
breast cancer cell migration and invasion. J Exp Med.
207:2421–2437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng Y, Chen MH, Moskowitz IP, Mendonza
AM, Vidali L, Nakamura F, Kwiatkowski DJ and Walsh CA: Filamin a
(FLNA) is required for cell-cell contact in vascular development
and cardiac morphogenesis. Proc Natl Acad Sci USA. 103:19836–19841.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Kreisberg JI, Bedolla RG,
Mikhailova M, deVere White RW and Ghosh PM: A 90 kDa fragment of
filamin A promotes casodex-induced growth inhibition in
Casodex-resistant and rogen receptor positive C4-2 prostate cancer
cells. Oncogene. 26:6061–6070. 2006. View Article : Google Scholar
|
|
17
|
Kyndt F, Gueffet JP, Probst V, Jaafar P,
Legendre A, Le Bouffant F, Toquet C, Roy E, McGregor L, Lynch SA,
et al: Mutations in the gene encoding filamin a as a cause for
familial cardiac valvular dystrophy. Circulation. 115:40–49. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura F, Heikkinen O, Pentikainen OT,
Osborn TM, Kasza KE, Weitz DA, Kupiainen O, Permi P, Kilpeläinen I,
Ylänne J, et al: Molecular basis of filamin A-FilGAP interaction
and its impairment in congenital disorders associated with filamin
a mutations. PLoS One. 4:e49282009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou AX, Hartwig JH and Akyurek LM:
Filamins in cell signaling transcription and organ development.
Trends Cell Biol. 20:113–123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu TN, He HJ, Kole S, D'Souza T, Agarwal
R, Morin PJ and Bernier M: Filamin A-mediated downregulation of the
exchange factor Ras-GRF1 correlates with decreased matrix
metalloproteinase-9 expression in human melanoma cells. J Biol
Chem. 282:14816–14826. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yarden Y and Sliwkowski MX: Untangling the
ErbB signalling network. Nat Rev Mol Cell Biology. 2:127–137. 2001.
View Article : Google Scholar
|
|
22
|
Roskoski R: The ErbB/HER family of
protein-tyrosine kinases and cancer. Pharmacol Res. 79:34–74. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yewale C, Baradia D, Vhora I, Patil S and
Misra A: Epidermal growth factor receptor targeting in cancer: A
review of trends and strategies. Biomaterials. 34:8690–8707. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
David II, Gallo RM and Settleman J:
Mutational activation of ErbB family receptor tyrosine kinases:
Insights into mechanisms of signal transduction and tumorigenesis.
Bioessays. 29:558–565. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lo HW: EGFR targeted therapy in malignant
Glioma: Novel aspects and mechanisms of drug resistance. Curr Mol
Pharmacol. 3:37–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Navolanic PM, Steelman LS and McCubrey JA:
EGFR family signaling and its association with breast cancer
development and resistance to chemotherapy. Int J Oncol.
22:237–252. 2003.PubMed/NCBI
|
|
27
|
Park OK, Schaefer TS and Nathans D: In
vitro activation of Stat3 by epidermal growth factor receptor
kinase. Proc Natl Acad Sci USA. 93:13704–13708. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2013. View Article : Google Scholar
|
|
29
|
Mclendon RE, Turner K, Perkinson K and
Rich J: Second messenger systems in human gliomas. Arch Pathol Lab
Med. 131:1585–1590. 2007.PubMed/NCBI
|
|
30
|
Wang CZ, Xie JT, Zhang B, Ni M, Fishbein
A, Aung HH, Mehendale SR, Du W, He TC and Yuan CS: Chemopreventive
effects of Panax notoginseng and its major constituents on SW480
human colorectal cancer cells. Int J Oncol. 31:1149–1156.
2007.PubMed/NCBI
|
|
31
|
Kaleağasıoğlu F and Berger MR:
Differential effects of erufosine on proliferation, wound healing
and apoptosis in colorectal cancer cell lines. Oncol Rep.
31:1407–1416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
LI K, Zhou ZY, JI PP and Luo HS: Knockdown
of β-catenin by siRNA influences proliferation, apoptosis and
invasion of the colon cancer cell line SW480. Oncol Lett.
11:3896–3900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakano H, Miyazawa T, Kinoshita K, Yamada
Y and Yoshida T: Functional screening identifies a microRNA,
miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal
cancer cells. Int J Cancer. 127:1072–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cardoso AP, Pinto ML, Pinto AT, Oliveira
MI, Pinto MT, Gonçalves R, Relvas JB, Figueiredo C, Seruca R,
Mantovani A, et al: Macrophages stimulate gastric and colorectal
cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and akt
phosphorylation and smallGTPase activity. Oncogene. 33:2123–2133.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Begonja AJ, Hoffmeister KM, Hartwig JH and
Falet H: FlnA-null megakaryocytes prematurely release large and
fragile platelets that circulate poorly. Blood. 118:2285–2295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Popowicz GM, Schleicher M, Noegel AA and
Holak TA: Filamins: Promiscuous organizers of the cytoskeleton.
Trends Biochem Sci. 31:411–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martin GS: Cell signaling and cancer.
Cancer Cell. 4:167–174. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang K, Ash JF and Singer SJ: Filamin, a
new high-molecular- weight protein found in smooth muscle and
nonmuscle cells. Proc Natl Acad Sci USA. 72:4483–4486. 1977.
View Article : Google Scholar
|
|
39
|
Ehrlicher AJ, Nakamura F, Hartwig JH,
Weitz DA and Stossel TP: Mechanical strain in actin networks
regulates FilGAP and integrin binding to filamin a. Nature.
478:260–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yi WY, Hong W, Kang HJ, Kim HJ, Zhao W,
Wang A, Seong YS and Bae I: Inhibition of the PI3K/Akt pathway
potentiates cytotoxicity of EGFR kinase inhibitors in
triple-negative breast cancer cells. J Cell Mol Med. 17:648–656.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abrams SL, Steelman LS, Shelton JG, Wong
EW, Chappell WH, Bäsecke J, Stivala F, Donia M, Nicoletti F, Libra
M, et al: The Raf/MEK/ERK pathway can govern drug resistance,
apoptosis and sensitivity to targeted therapy. Cell Cycle.
9:1781–1791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu Y, Bismar TA, Su J, Xu B, Kristiansen
G, Varga Z, Teng L, Ingber DE, Mammoto A, Kumar R and Alaoui-Jamali
MA: Filamin a regulates focal adhesion disassembly and suppresses
breast cancer cell migration and invasion. J Exp Med.
207:2421–2437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Uramoto H, Akyurek LM and Hanagirl T: A
positive relationship between Filamin and VEGF in patiens with lung
cancer. Anticancer Res. 30:3939–3944. 2010.PubMed/NCBI
|
|
44
|
Park YL, Park SY, Lee SH, Kim RB, Kim JK,
Rew SY, Myung DS, Cho SB, Lee WS, Kim HS and Joo YE: Filamin a
interacting protein 1-like expression inhibits progression in
colorectal cancer. Oncotarget. 7:72229–72241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun GG, Sheng SH, Jing SW and Hu WN: An
antiproliferative gene FLNA regulates migration and invasion of
gastric carcinoma cell in vitro and its clinical significance.
Tumor Biol. 3:2641–2648. 2014. View Article : Google Scholar
|
